However, the neutralization of IL-17 or depletion of MDSCs blunted such upregulation (Fig. 6, A and B), suggesting that mast cells enhance Treg cells expressing IL-9 via IL-17 signaling pathway in tumor microenvironment. This evidence concerns the gene IL17A and neoplasm.